|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Psoriasis | |||||
| 2 | More general conditions related to this trial | ||||
| Skin Diseases | |||||
| Skin Diseases, Papulosquamous | |||||
| 3 | Interventions listed in this trial | ||||
| calcitriol | |||||
| 4 | More general drug interventions related to this trial | ||||
| Bone Density Conservation Agents | |||||
| Calcium Channel Agonists | |||||
| Cardiovascular Agents | |||||
| Growth Substances | |||||
| Membrane Transport Modulators | |||||
| Micronutrients | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vasoconstrictor Agents | |||||
| Vitamins | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| Boston University | |||||